TRANSBIG, the MINDACT trial and/or the 70-gene signature in the news:
Articles
Keeping in touch: on clinical trials, communication and breast care nursing, about MINDACT. Europa Donna News - Summer/Automn 2007
A new test predicts whether breast cancer will return Daily Mail – February 2007
Genes revelem o futuro Expresso – August 2005
European Research crisis: placebos are not enough Cancer World– July-August 2005
It would be advantageous to reduce chemotherapy in breast cancer. Interview with Fatima Cardoso Público – April 2005
Multiple Gene Signatures Aim to Qualify Risk in Breast Cancer, Trial and error: Prognostic Gene Signature Study Design Altered Journal of the National Cancer Institute –March 2005
A Big Trial For New Technologies: TRANSBIG Project takes microarrays Into Clinical Trials Journal of the National Cancer Institute – May 2004
First large-scale trial of genetically personalised treatment for breast cancer to start soon Medical News Today - March 2004
Up close, and personal The Economist October 2004
Press releases
First large-scale trial of genetically personalised treatment for breast cancer to start soon. EBCC-4, March 2004, Launch of TRANSBIG.
Encouraging results from validation study give green light for a trial of personalized treatment in breast cancer. San Antonio Breast Cancer Symposium, December 2004
Clears Breast Cancer Specific Molecular Prognostic Test – FDA News, February 6th 2007
Other
Tailored treatments for breast cancer - TRANSBIG, in Research for Europe. A selection of EU success stories, published by the EU Directorate-General for Research, 2008
To find out about TRANSBIG publications click here.